Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Breast Neoplasms 53Neoplasms 36Lung Neoplasms 24Colorectal Neoplasms 23Prostatic Neoplasms 17Uterine Cervical Neoplasms 14Motor Activity 13Colonic Neoplasms 11Carcinoma, Non-Small-Cell Lung 10Rectal Neoplasms 9Anxiety Disorders 9Urinary Bladder Neoplasms 8Obesity 8Melanoma 8Depression 8Pancreatic Neoplasms 7Lymphoma 7Hematologic Neoplasms 7Endometrial Neoplasms 7Vulvar Neoplasms 6Ovarian Neoplasms 6Head and Neck Neoplasms 6Breast Carcinoma In Situ 6Sarcoma 5Pain 5Hematopoietic and Lymphatic System Neoplasm 5Triple Negative Breast Neoplasms 4Stomach Neoplasms 4Papillomavirus Infections 4Neoplasm Metastasis 4

Interventions

Standard of Care 1Practice Guidelines as Topic 1Methods 1Interviews as Topic 1Educational Status 1Early Intervention, Educational 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Arthritis, Reactive × Methods × Clear all
NCT04751396 2026-05-20

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

M.D. Anderson Cancer Center

Recruiting
125 enrolled
Dermatologic

Arthritis, Rheumatoid, Autoimmune Diseases, Colitis, Ulcerative, Crohn Disease, Lupus Erythematosus, Systemic, Melanoma, Psoriasis, Spondylitis, Ankylosing, Inflammatory Bowel Diseases, Arthritis, Psoriatic, Arthritis, Reactive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡